On October 28th, Heshi Eye Care (SZ301103, stock price 22.39 yuan, market cap 3.538 billion yuan) announced that the company will jointly invest with Shenzhen Merchants Guoxie Equity Investment Fund Management Co., Ltd. (hereinafter referred to as 'Guoxie No.2') and Maotai Zhaohua (Guizhou) Industrial Development Fund Partnership Enterprise (Limited Partnership) (hereinafter referred to as 'Maotai Zhaohua'), to establish the Zhaohua (Guizhou) Health Technology Industry Development Fund Partnership Enterprise (Limited Partnership) (the final name shall be subject to the industrial and commercial registration, hereinafter referred to as 'Zhaohua Health Fund'). The total capital of Zhaohua Health Fund is 0.797 billion yuan, of which Guoxie No.2 has subscribed 3 million yuan, Maotai Zhaohua has subscribed 0.554 billion yuan, and Heshi Eye Care has subscribed 0.24 billion yuan, with subscription ratios of 0.376%, 69.511%, and 30.113% respectively. Zhaohua Health Fund will focus on eye health, mainly investing in the fields of new generation medical health, dietary nutrition, and synthetic biology. Previously, Maotai Group's funds have laid out the health industry through equity investments multiple times. (Yijing)